Shahneen Sandhu

机构：The University of Melbourne, Peter MacCallum Cancer Centre · ORCID：0000-0002-8660-4475

发表论文 646 篇 · 总被引 36409 次 · h-index 81

代表论文

• Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial (2025 · Nature Medicine · 被引 56)
• Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma (2025 · Immunity · 被引 28)
• Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma (2025 · Annals of Oncology · 被引 5)
• Prognostic Value of Initial Imaging and PSA Change with [ 177 Lu]Lu-PSMA-617 Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A ProsTIC Registry Analysis (2025 · Journal of Nuclear Medicine · 被引 5)
• Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells (2025 · medRxiv · 被引 3)
• Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial (2026 · Nature Cancer · 被引 2)